RU2003116131A - APPLICATION OF ENZYMES OBTAINED FROM INFUSORIES AS AN ASSOCIATED DIGESTIVE MEDICINES - Google Patents
APPLICATION OF ENZYMES OBTAINED FROM INFUSORIES AS AN ASSOCIATED DIGESTIVE MEDICINESInfo
- Publication number
- RU2003116131A RU2003116131A RU2003116131/15A RU2003116131A RU2003116131A RU 2003116131 A RU2003116131 A RU 2003116131A RU 2003116131/15 A RU2003116131/15 A RU 2003116131/15A RU 2003116131 A RU2003116131 A RU 2003116131A RU 2003116131 A RU2003116131 A RU 2003116131A
- Authority
- RU
- Russia
- Prior art keywords
- enzymes
- drug
- ciliates
- drug according
- infusories
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims 8
- 102000004190 Enzymes Human genes 0.000 title claims 5
- 108090000790 Enzymes Proteins 0.000 title claims 5
- 230000001079 digestive Effects 0.000 title claims 3
- 229940079593 drugs Drugs 0.000 claims 6
- 241000223782 Ciliophora Species 0.000 claims 3
- 102000013142 Amylases Human genes 0.000 claims 2
- 108010065511 Amylases Proteins 0.000 claims 2
- 229940025131 Amylases Drugs 0.000 claims 2
- 102000005744 Glycoside Hydrolases Human genes 0.000 claims 2
- 108010031186 Glycoside Hydrolases Proteins 0.000 claims 2
- 102000004157 Hydrolases Human genes 0.000 claims 2
- 108090000604 Hydrolases Proteins 0.000 claims 2
- 239000004367 Lipase Substances 0.000 claims 2
- 102000035443 Peptidases Human genes 0.000 claims 2
- 108091005771 Peptidases Proteins 0.000 claims 2
- 102000015439 Phospholipases Human genes 0.000 claims 2
- 108010064785 Phospholipases Proteins 0.000 claims 2
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 claims 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 claims 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 2
- 239000004365 Protease Substances 0.000 claims 2
- 235000019418 amylase Nutrition 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 201000006549 dyspepsia Diseases 0.000 claims 2
- 102000004882 lipase Human genes 0.000 claims 2
- 108090001060 lipase Proteins 0.000 claims 2
- 235000019421 lipase Nutrition 0.000 claims 2
- 208000000668 Chronic Pancreatitis Diseases 0.000 claims 1
- 241000248395 Colpidium Species 0.000 claims 1
- 208000007882 Gastritis Diseases 0.000 claims 1
- 206010033647 Pancreatitis acute Diseases 0.000 claims 1
- 206010033649 Pancreatitis chronic Diseases 0.000 claims 1
- 241000223785 Paramecium Species 0.000 claims 1
- 241000223892 Tetrahymena Species 0.000 claims 1
- 201000003229 acute pancreatitis Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000001684 chronic Effects 0.000 claims 1
- 201000003883 cystic fibrosis Diseases 0.000 claims 1
- 239000008298 dragée Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10054239.5 | 2000-11-02 | ||
DE10054239 | 2000-11-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2003116131A true RU2003116131A (en) | 2004-12-20 |
RU2299074C2 RU2299074C2 (en) | 2007-05-20 |
Family
ID=7661849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2003116131/15A RU2299074C2 (en) | 2000-11-02 | 2001-11-02 | Using enzymes prepared from infusoria as digestion-promoting medicinal agents |
Country Status (17)
Country | Link |
---|---|
US (2) | US20040033220A1 (en) |
EP (1) | EP1330262B1 (en) |
JP (1) | JP4139215B2 (en) |
CN (1) | CN1262308C (en) |
AT (1) | ATE295737T1 (en) |
AU (2) | AU2366602A (en) |
CA (1) | CA2427537A1 (en) |
DE (1) | DE50106273D1 (en) |
DK (1) | DK1330262T3 (en) |
ES (1) | ES2239686T3 (en) |
HK (1) | HK1057861A1 (en) |
IL (2) | IL155515A0 (en) |
NO (1) | NO20031979L (en) |
PL (1) | PL204599B1 (en) |
PT (1) | PT1330262E (en) |
RU (1) | RU2299074C2 (en) |
WO (1) | WO2002036156A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7459155B2 (en) * | 2003-10-29 | 2008-12-02 | Altus Pharmaceuticals Inc. | Treating abdominal pain due to pancreatitis with seaprose |
AU2005227090B2 (en) * | 2004-03-22 | 2010-12-09 | Abbott Laboratories Gmbh | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
WO2005098427A2 (en) * | 2004-04-05 | 2005-10-20 | Arbab Saccharides Science & Technology Co. Ltd | Method, composition and device for treating starch related diseases |
WO2005099748A1 (en) * | 2004-04-13 | 2005-10-27 | Cilian Ag | Recombinant lysosomal enzymes comprising a glycosylation pattern typical of ciliates for treatment |
KR101555058B1 (en) * | 2005-07-29 | 2015-09-22 | 애보트 래버러토리즈 게엠베하 | Processes for the Manufacture of Sterilized Pancreatin Powder |
US11266607B2 (en) * | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US8071089B2 (en) * | 2005-11-01 | 2011-12-06 | Bio-Cat, Inc. | Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency |
US10072256B2 (en) * | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
US20110171294A1 (en) * | 2008-09-30 | 2011-07-14 | Dsm Ip Assets B.V. | Enzyme composition and application thereof in the treatment of pancreatic insufficiency |
GB201501081D0 (en) * | 2015-01-22 | 2015-03-11 | Cilian Ag | Use of enzymes with a wide pH activity range as medicaments for promoting digestion |
AU2022254851A1 (en) * | 2021-04-09 | 2023-11-23 | Cilian Ag | Purification of proteins |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE454566B (en) * | 1984-04-24 | 1988-05-16 | Lars G I Hellgren | PHARMACEUTICAL COMPOSITION CONTAINING AN ACTIVE AMOUNT OF WATER-SOLUBLE PROTEINASES EXTRACTED FROM A WATER-LIVING ANIMAL SELECTED BY THE EUPHAUSIACEAE OR GENERAL MALLOTUS |
CA2110497C (en) * | 1991-07-01 | 2005-04-19 | Reinhard Braatz | Use of bacterial lipases for producing drugs for maldigestion therapy |
DE19524307A1 (en) * | 1995-07-07 | 1997-01-09 | Hoechst Ag | Process for the mass cultivation of ciliates |
DE19724845A1 (en) * | 1996-08-28 | 1998-03-05 | Solvay Pharm Gmbh | Use of complex lipids as stabilizing additives for pharmaceutical preparations of digestive enzyme mixtures |
US6846481B1 (en) * | 1999-02-04 | 2005-01-25 | University Of Georgia Research Foundation, Inc. | Recombinant expression of heterologous nucleic acids in protozoa |
US6539128B1 (en) * | 1999-04-16 | 2003-03-25 | Macronix International Co., Ltd. | Method and apparatus for interpolation |
US6543100B1 (en) * | 2001-09-24 | 2003-04-08 | Christopher J. Finley | Test tube retention system |
-
2001
- 2001-11-02 US US10/399,551 patent/US20040033220A1/en not_active Abandoned
- 2001-11-02 ES ES01992585T patent/ES2239686T3/en not_active Expired - Lifetime
- 2001-11-02 JP JP2002538965A patent/JP4139215B2/en not_active Expired - Fee Related
- 2001-11-02 PT PT01992585T patent/PT1330262E/en unknown
- 2001-11-02 AU AU2366602A patent/AU2366602A/en active Pending
- 2001-11-02 CA CA002427537A patent/CA2427537A1/en not_active Abandoned
- 2001-11-02 AT AT01992585T patent/ATE295737T1/en not_active IP Right Cessation
- 2001-11-02 PL PL361630A patent/PL204599B1/en unknown
- 2001-11-02 IL IL15551501A patent/IL155515A0/en active IP Right Grant
- 2001-11-02 RU RU2003116131/15A patent/RU2299074C2/en not_active IP Right Cessation
- 2001-11-02 DK DK01992585T patent/DK1330262T3/en active
- 2001-11-02 DE DE50106273T patent/DE50106273D1/en not_active Expired - Lifetime
- 2001-11-02 EP EP01992585A patent/EP1330262B1/en not_active Expired - Lifetime
- 2001-11-02 AU AU2002223666A patent/AU2002223666B2/en not_active Ceased
- 2001-11-02 WO PCT/EP2001/012740 patent/WO2002036156A1/en active IP Right Grant
- 2001-11-02 CN CNB018217109A patent/CN1262308C/en not_active Expired - Lifetime
-
2003
- 2003-04-20 IL IL155515A patent/IL155515A/en not_active IP Right Cessation
- 2003-04-30 NO NO20031979A patent/NO20031979L/en not_active Application Discontinuation
-
2004
- 2004-01-30 HK HK04100660A patent/HK1057861A1/en unknown
-
2007
- 2007-07-25 US US11/878,618 patent/US20080292610A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2003116131A (en) | APPLICATION OF ENZYMES OBTAINED FROM INFUSORIES AS AN ASSOCIATED DIGESTIVE MEDICINES | |
RU2001126526A (en) | Diabetes drug | |
RU94028653A (en) | Pharmaceutical preparation | |
HUP0500560A2 (en) | Mixtures of mushroom enzymes and the use thereof for treating maldigestion | |
SE9600072D0 (en) | New oral formulation of two active ingredients II | |
CA2367355A1 (en) | Medicinal product for the treatment of diabetes | |
IT1296980B1 (en) | DOUBLE CAPSULE AS A PHARMACEUTICAL FORM FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS IN MULTIPLE THERAPIES | |
MXPA03006364A (en) | Treatment of sleep disturbances. | |
HUP0401569A2 (en) | Pharmaceutical compositions of amlodipine and atorvastatin and process for their preparation | |
RU99118887A (en) | APPLICATION OF GASTROINTESTINAL LIPASE INHIBITORS | |
BR9814214B1 (en) | azelaic acid composition. | |
PT1330262E (en) | USE OF ENZYMES OBTAINED FROM LILIATES AS MEDICINES TO FACILITATE DIGESTION | |
CN102008464A (en) | Application of levobutyl phthalide in preparation of medicament for preventing and treating cerebral infarction | |
WO2001043754A3 (en) | Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases | |
ATE401394T1 (en) | IMPROVED DNASE LIQUID SOLUTIONS | |
EA200401295A1 (en) | STATIN THERAPY TO ENHANCE SUPPORT OF COGNITIVE FUNCTION | |
PT1208078E (en) | NON-HYGROSCOPIC SALTS OF ACTIVE SUBSTANCES WITH THERAPEUTIC AND / OR NUTRITIONAL ACTIVITIES AND PASSIVE COMPOSITIONS TO BE ADMINISTERED ORALLY CONTAINING THE SAME | |
BR9814146A (en) | Composition, process for making it, process for treating HIV infection, process for treating AIDS, and pharmaceutical composition. | |
Vazquez | New protease inhibitor | |
BR0113101A (en) | Use of a lipase inhibitor and oral process and medicament for treating, reducing or preventing functional dyspepsia | |
JP2004505914A5 (en) | ||
Belachew | Enzymes for Disease Treatment: A Review | |
Torres | New saquinavir formulation enters clinical trials | |
CN1060057C (en) | "Hantongling" | |
Highleyman | Expanded access program begins |